Processa Pharmaceuticals Inc (NASDAQ:PCSA)
| 3.12 Delayed Data As of 3:59pm ET |  +0.31 / +11.03%Today’s Change | 1.50 Today|||52-Week Range 8.99 | -36.33% Year-to-Date |
Latest PCSA News | Press Releases
No recent news for Processa Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.81 |
| Today’s open | 3.12 |
| Day’s range | 3.12 - 3.12 |
| Volume | 263 |
| Average volume (3 months) | 29,238 |
| Market cap | $24.1M |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +70.61% |
| Earnings growth (this year) | -18.33% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.87 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$11.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Hanover, Maryland |
Forecasts
